MedTrace Logo

Dexamethasone-bupivacaine Versus Bupivacaine for Tonsillectomy Pain.

NCT03443778 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2018-02-23

No results posted yet for this study

Summary

Investigators compared in this study peritonsillar infiltration of bupivacaine %0.5 (n=40 participants) versus bupivacaine % 0.5 and dexamethasone (number 40participants ) before surgery for reduce posttonsillectomy pain.And control group (n= 40participants) participants received peritonsillar Nacl 0,9% .

Conditions

  • Tonsillectomy

Interventions

DRUG

Bupivacaine 0.5%

Marcaine 0.5% Injectable Solution

DRUG

Bupivacaine 0.5% , Dexamethasone

Bupivacaine 0.5% , Dexamethasone

DRUG

Nacl 0,9 %

Injectable Solution

Sponsors & Collaborators

  • Sisli Hamidiye Etfal Training and Research Hospital

    lead OTHER

Principal Investigators

  • Leyla Kilinc, Md · Md

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-15
Primary Completion
2018-03-15
Completion
2018-04-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03443778 on ClinicalTrials.gov